I am a researcher at Harvard & UCL studying the effects of frontier technologies like AI and synthetic biology. I am also a Marshall Scholar intending to study topics related to AI and innovation at UCL and the University of Oxford. I am also a researcher on Eric Schmidt's team at the Office of Eric Schmidt.

I previously co-founded the Emerging Technology Group, which researched topics like adversarial attacks on LLMs. I grew our 5-person team to an organization that received support from Schmidt Futures and launched 13 collaborations with entities like IBM and Gingko Bioworks. I am also a published researcher with papers in JAMA, the BMJ, and Nature Biotech, and work in The Hill, Newsweek, and The Diplomat.

For my work, I was invited to present to the White House and address the United Nations. I was also selected to write two advisory briefs on AI and synthetic biology for global ministers at the United Nations, was a named contributor to a United Nations report on digital transformation, and presented my research to offices in the U.S. Congress. My work has been cited in 3 U.S. House and Senate hearings, by experts from the World Bank, OECD, and in consultations over a new treaty. My work has also been featured 120+ times in news outlets like The Washington Post, NBC, and more.